Literature DB >> 3005560

Systemic sclerosis and malignancy--are they related?

T A Medsger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3005560

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma.

Authors:  N Giordano; L Magaro; L Fattorini; P Marcucci; E Battisti; A Fioravanti; R Marcolongo
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

2.  Scleroderma and malignancy: an epidemiological study.

Authors:  A K Rosenthal; J K McLaughlin; M S Linet; I Persson
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

Review 3.  Thyroid disorders in patients with progressive systemic sclerosis: a review.

Authors:  E J Kucharz
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 4.  Combination therapy: the risks of infection and tumor induction.

Authors:  D E Yocum
Journal:  Springer Semin Immunopathol       Date:  2001

5.  Systemic sclerosis in association with multiple primary pulmonary malignancy--a marker of internal malignancy?

Authors:  M J Goodfield; L G Millard
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.